GX Acquisition Corp. (GXGX) Shareholders Approve Celularity Group Deal
GX Acquisition Corp. (NASDAQ:GXGX) announced in an 8-K filing this morning that its shareholders approved its combination with clinical stage biotech firm Celularity in a meeting earlier this morning. Shareholders redeemed 9,174,705 share in connection with the vote, however, removing about $93.6 million (about 73%) from its $128 million trust. This is the latest inRead More